SERNOVA BIOTHERAPEUTICS INC (PSH0.DE) Stock Income Statement
FRA:PSH0 • CA81752F1062
0.0915 EUR
+0 (+0.55%)
Last: Feb 16, 2026, 07:00 PM
| 2025 (2025-10-31) | 2024 (2024-10-31) | 2023 (2023-10-31) | 2022 (2022-10-31) | 2021 (2021-10-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 15.02M | 31.66M | 40.50M | 24.75M | 6.94M | |||
| Research and Development | 7.18M | 22.18M | 31.63M | 16.49M | 4.38M | |||
| Selling, General, and Administrative Expenses | 7.50M | 8.94M | 8.43M | 7.83M | 2.29M | |||
| Operating Income | -15.02M | -31.66M | -40.50M | -24.75M | -6.94M | |||
| Interest Income/Expense | -766.20K | -540.30K | 1.50M | 333.20K | 19.20K | |||
| Other Income/Expense | N/A | N/A | N/A | N/A | -48.20K | |||
| Income Before Taxes | -15.73M | -32.19M | -39.00M | -24.42M | -6.97M | |||
| Income Tax | 9.40K | 7.00K | N/A | N/A | N/A | |||
| Net Income | -15.74M | -32.19M | -39.00M | -24.42M | -6.97M | |||
| EBITDA | -14.68M | -31.12M | -40.06M | -24.31M | -6.67M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.05 | -0.10 | -0.13 | -0.09 | -0.03 | |||
| Non GAAP EPS | N/A | -0.09 | -0.13 | -0.09 | N/A | |||
| Statistics | ||||||||
All data in CAD